SHAWNA WHITE: Open Payments
NPI 1134841992 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,763 in 80 payments from 20 companies in 2025. Trend: 2023 $1,427 · 2024 $1,429 · 2025 $1,763
Food & beverage: $1,763
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $257 |
| Otsuka America Pharmaceutical, Inc. | 11 | $207 |
| Braeburn Inc. | 4 | $142 |
| Neurocrine BioSciences, Inc. | 7 | $119 |
| Almatica Pharma LLC | 6 | $116 |
| ABBVIE INC. | 6 | $111 |
| Janssen Pharmaceuticals, Inc | 4 | $105 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $88 |
| Indivior Inc. | 5 | $88 |
| Neos Therapeutics, LP | 4 | $77 |
Products named: FANAPT, REXULTI, BRIXADI, INGREZZA, LOREEV XR, VRAYLAR, SPRAVATO, CAPLYTA.
Industry payments across NC — which companies pay providers there.
